Similar Search Results

Pay-for-delay patent settlement, generic entry and welfare

Ding, Yucheng; Zhao, Xin - In: International journal of industrial organization 67 (2019), pp. 1-18

Persistent link: https://www.econbiz.de/10012321579

Starving (or fattening) the golden goose? : generic entry and the incentives for early-stage pharmaceutical innovation

Branstetter, Lee; Chatterjee, Chirantan; Higgins, Matthew J. - 2014

Persistent link: https://www.econbiz.de/10010421600

Generic competition and the incentives for early-stage pharmaceutical innovation

Branstetter, Lee; Chatterjee, Chirantan; Higgins, Matthew J. - In: Research policy : policy, management and economic … 51 (2022) 10, pp. 1-19

Persistent link: https://www.econbiz.de/10014229272

Regulation and welfare : evidence from Paragraph IV generic entry in the pharmaceutical industry

Branstetter, Lee; Chatterjee, Chirantan; Higgins, Matthew J. - 2011

Persistent link: https://www.econbiz.de/10009234148

Pharmaceutical followers

Arcidiacono, Peter; Ellickson, Paul B.; Landry, Peter; … - 2013

Persistent link: https://www.econbiz.de/10010200106

Pharmaceutical followers

Arcidiacono, Peter; Ellickson, Paul B.; Landry, Peter; … - 2013

We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded and generic drugs within and across therapeutic classes. We use data on antiulcer drugs from 1991 to 2010. Our simulations show generics and "me-too" drugs each increased...

Persistent link: https://www.econbiz.de/10010250679